Navigation Links
Burnham Institute for Medical Research and Magellan BioScience Group, Inc. Announce Drug Discovery Collaboration
Date:7/7/2009

ied and industry-experienced research teams constitutes a significant opportunity for the discovery and development of new pharmaceutical candidates.”

Burnham’s ultra-high throughput screening resource resides within the Conrad Prebys Center for Chemical Genomics and is one of four NIH sponsored comprehensive screening and probe development centers in the United States. The fully-integrated automated system combines robotic screening with high-content image analysis, hit-to-probe chemistry, exploratory pharmacology expertise, and informatics, provides a technology platform that is virtually unprecedented in the not-for-profit research world.

“The Burnham-Magellan collaboration will involve some of the first assays to be processed through our new small molecule screening center at Lake Nona. This is a powerful partnership that will advance both science and regional development and is representative of the collaborations that were envisioned by Burnham as we established an east coast campus in Florida,” said Dr. Gregory Roth, associate professor and director of medicinal chemistry and pharmacology at Burnham.

About Magellan:
Magellan BioScience Group, Inc., based in Tampa, Fla., is a privately held innovative biotechnology company focused on the discovery of novel classes of therapeutic candidates. Magellan is using its integrated platform technologies to isolate and identify new biologically active compounds. The company believes that its library of marine microbes will be the next source of drug discovery for the pharmaceutical industry. Magellan aims to develop and optimize drug candidates to treat cancer, infectious diseases, and inflammation. For additional information, please refer to the company’s web site at Magellan BioScience Group, Inc..

About B
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

0

GOOD

Page: 1 2 3

Related biology technology :

1. Burnham Announces Assay Development and License Agreement with Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
2. The Burnham Institute for Medical Research Becomes a GeneGo Center of Excellence Using MetaCore for Stem Cell Research and Neurology
3. Cyntellect to Collaborate With the Burnham Institute for Medical Research
4. Pharmaceutical Institute Launches New E-Course Focused on Health Policy
5. National Institutes of Health Join Nations Leading Postgrad Bio Jobs Board
6. DNA Genotek Partners with Roswell Park Cancer Institute to Accelerate Breast Cancer Research
7. Scripps Research Institute Highlights Groundbreaking Work of aTyr Pharma Scientific Co-Founder
8. Orange County Laser Surgeon Nissan Pilest Tapped as Keynote Speaker at Fraxel & Thermage User Forum Held at Beckman Laser Institute
9. Kornberg Associates Architects Selected to Design Research Areas of Malaysia Genome Institute
10. AGA Institute and Horizon Therapeutics Launch Connect to Protect Program to Educate Physicians and Consumers on Risks Associated With NSAID Use
11. Genomas and Institute of Living Among Organizers of Pharmacogenetics Symposium at 2009 Annual Meeting of the American Psychiatric Association

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Burnham Institute for Medical Research and Magellan BioScience Group, Inc. Announce Drug Discovery Collaboration
Burnham Institute for Medical Research and Magellan BioScience Group, Inc. Announce Drug Discovery Collaboration
(Date:11/20/2009)...LER TOLEDO recently announced that a free webinar,...ing At-Line Particle Characterization”, will...r, the application of in situ particle characteriz...optimize a series of roller compaction runs while ...action forces. , (PRWEB) ...
(Date:11/19/2009).... 19 Dr. Mate Hidvegi, inventor of...a press release issued on November 17 by Biropharm...ng false and self-serving statements about its U.S...egi stated from his office in Budapest, Hungary: ...r does not apply to AveULTRA, www.aveultra.com ...
(Date:11/19/2009)...many, November 19 MONITORING FORCE...6th, 2009 Flibanserin in the,indication treatment-...s,disease for orphan drug status designation with ...uced dyskinesia is a complication of the mainstay,...rden to some of those,affected, since it may be di...
(Date:11/19/2009)...tria, November 19 AFFiRiS AG will ...ct candidate at an unexpectedly early,stage of dev... enter into,Phase II clinical trial early in 2010....the completion of two Phase I trials with the cand...ecision on the first interim,analysis of the secon...
Breaking Biology Technology:Roller Compaction Process Optimization Using At-Line Particle Characterization 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3
...posed a joint public-private initiative to allocat...f renewable energy programs in Wisconsin. , ,Doyle...interest loans, and grants that would come from bu... state bonds - would leverage an additional $370 m...esources around biofuels. , ,"As I,ve always said,...
...sponders contained the recent E. coli outbreak qui...sionals, the automated system used to identify the...for improvement. , ,Still, information technology ...als of the recent outbreak, and it will play an ev...cording to Wisconsin and national health experts. ...
...g an online application provider, have won the 200...y the Eau Claire Area Economic Development Corp ....wth categories, respectively, were STAGE5, LLC, an...e appointment software, and KingBuilt.com, Inc .,... addition to recognition, winning has other reward...
Other Biology Technology:Doyle announces $80M renewable energy strategy 2Doyle announces $80M renewable energy strategy 3Doyle announces $80M renewable energy strategy 4Technology played key role in E. coli alerts 2Technology played key role in E. coli alerts 3Technology played key role in E. coli alerts 4Eau Claire business contest honors tech start ups 2
(Date:11/20/2009)... introduction of a single bacterial gene into yeas... in the Netherlands achieved three improvements in...erial: ,More ethanol, less acetate and elimination...nvention was published in the scientific journal ...fuel , Bioethanol is made by the yeast Saccharo...
(Date:11/20/2009)...niversity,s Energy Research Center (ERC) has been ... (DOE) to develop methods of recovering and reusin...ioxide (CO 2 ) compression process in a carbon cap...o facilitate carbon capture and sequestration, or ... a greenhouse gas, emitted into the atmosphere by ...
(Date:11/19/2009)... This week, scientists are revealing the genetic i...al crops. Corn, or maize, has one of the most comp...y of Wisconsin-Madison genomicist David Schwartz, ...e in the journal Science . , "The maize genome ...-ends that have troubled would-be sequencers for y...
Breaking Biology News(10 mins):Delft breakthrough in bioethanol production from agricultural waste 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 3Sweet corn story begins in UW-Madison lab 2Sweet corn story begins in UW-Madison lab 3ADVENTRX Pharmaceuticals Announces Closing of Financing 50825 1ADVENTRX Pharmaceuticals Announces Closing of Financing 50825 2ADVENTRX Pharmaceuticals Announces Closing of Financing 50825 3ADVENTRX Pharmaceuticals Announces Closing of Financing 50825 4Lilly Sets Date and Conference Call for Second Quarter 2009 Financial Results Announcement 50821 1Ancient fossils shed light on anatomical changes accompanying evolution of first land vertebrates 50817 1Ancient fossils shed light on anatomical changes accompanying evolution of first land vertebrates 50817 2
...anse of Arctic sea ice is increasingly vulnerable ...udy, by scientists at the National Center for Atmo...ity (CSU), finds that unusually sunny weather cont..., while similar weather conditions in past summers...The study, which draws on observations from instru...
... of Illinois study have demonstrated an effective ...te bars. , Eating two CocoaVia dark chocolate bar...nexpected effect of also lowering systolic blood p... food science and human nutrition. , The study, f... the bars, was published in this months Journal of...
...view, scientists at Childrens Hospital & Research ...logical or behavioral evidence linking vitamin D d...h.D., assistant staff scientist and Bruce N. Ames,...land Research Institute (CHORI) conclude that ther...tant role for vitamin D in brain development and f...
Other Biology News:Arctic ice more vulnerable to sunny weather, new study shows 2Arctic ice more vulnerable to sunny weather, new study shows 3Chocolate bar shown to lower cholesterol 2Vitamin D in brain function 2Vitamin D in brain function 3
Mouse Anti-Human gp340 Monoclonal Antibody, Unconjugated, Clone HYB213-01 from MBL International
Mouse Anti-INSL3 Antibody, Unconjugated from Raybiotech, Inc.
Anti-MBPK Red, 20X Antibody, Unconjugated from Upstate
Mouse Anti-Kusabira Orange Monoclonal Antibody, Unconjugated, Clone 2G9 from MBL International
Biology Products: